Acceptability of Nutrient Supplements Among Women and Children in Bangladesh
Acceptability of Lipid-based Nutrient Supplements (LNS) and Micronutrient Powder (MNP) for Women and Infants in Bangladesh
2 other identifiers
interventional
144
1 country
1
Brief Summary
The study aims to confirm the acceptability of lipid-based nutrient supplements (LNS) for use as nutritional supplements for pregnant and lactating women (PLW) or infants and young children (IYC) and micronutrient powder (MNP) for use as nutritional supplements for infants and young children in Bangladesh.We hypothesized that at least 75 percent of the test dose of LNS and MNP offered to PLW and IYC will be consumed by them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 13, 2010
CompletedFirst Posted
Study publicly available on registry
May 24, 2010
CompletedSeptember 23, 2024
September 1, 2024
1 month
May 13, 2010
September 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of test dose consumed
Mean consumption of the test dose of LNS for PLW, LNS for IYC and MNP for IYC on day 2 (First test dose)
Day 2
Proportion of test dose consumed
Mean consumption of the test dose of LNS for PLW, LNS for IYC and MNP for IYC on day 3(Second test dose)
Day 3
Secondary Outcomes (4)
Proportion of subjects liked the supplements
Day 2
Proportion of subjects liked the supplement
Day 3
Proportion of subjects liked the supplement
Day 8
Proportion of subjects liked the supplement
Day 15
Study Arms (3)
LNS-PLW
EXPERIMENTALThere will be 48 pregnant or lactating women (PLW) in this arm. They will be randomized to receive cumin flavored LNS-PLW or LNS-PLW with no added flavor on day 2. On day 3, the PLW getting a test-dose of cumin flavored LNS-PLW on day 2 will receive LNS-PLW with no added flavor and the PLW getting a test-dose of LNS-PLW with no added flavor on day 2 will receive cumin flavored LNS-PLW.
LNS-Child
EXPERIMENTALThere will be 48 infant and young children(IYC) in this arm. They will be randomized to receive cardamom flavored LNS-Child or LNS-Child with no added flavor on day 2. On day 3, the IYC getting a test-dose of LNS-Child with no added flavor on day 2 will receive cardamom flavored LNS-Child and the IYC getting a test-dose of cardamom flavored LNS-Child on day 2 will receive LNS-Child with no added flavor.
MNP-Child
EXPERIMENTALThere will be 48 infant and young children(IYC) in this arm. They will receive MNP on day 2 and day 3.
Interventions
Lipid-based nutrient supplement for pregnant and lactating women
Micronutrient powder for infant and young children
Eligibility Criteria
You may qualify if:
- Pregnant women in their second or third trimester (in case of third trimester pregnancy, the expected date of delivery is not within three weeks) or lactating women with a child between 3 days and 6 months of age
- At least 18 years of age
- No life-threatening pregnancy-related complications (e.g., pre-eclampsia, antepartum hemorrhage)
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection)
- Living in the study area for at least 6 months
- Planning to remain in study area for at least the following three weeks.
You may not qualify if:
- Known allergy to peanuts or other food products (as reported on the screening questionnaire)
- Children 6-24 months of age
- Consuming solid foods for at least the past 30 days
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection)
- No known allergy to peanuts or other food products (as reported on the screening questionnaire by the mother/primary caregiver)\[LNS-Child only\]
- Planning to remain in study area for at least the following three weeks.
- Severely malnourished \[mid-upper arm circumference (MUAC) \< 115 mm\]
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatejangpur
Chirirbandar, Dinajpur, 5240, Bangladesh
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katnryn G Dewey, Ph.D.
University of California, Davis
- STUDY DIRECTOR
Malay K Mridha, MBBS,MPH
University of Callifornia, Davis
- STUDY DIRECTOR
Camila M Chaparro, Ph.D.
Academy for Educational Development
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2010
First Posted
May 24, 2010
Study Start
December 1, 2009
Primary Completion
January 1, 2010
Study Completion
February 1, 2010
Last Updated
September 23, 2024
Record last verified: 2024-09